Evidence map›Paper›PMID 42642864›Full record

ArticleClinical and experimental pharmacology & physiology2026

Early Cardiotoxic Remodelling Precedes Hepatic Fibrosis and Increases Susceptibility to Lethal Arrhythmias in Wild-Type MASH Mice.

Jinyao Liu, Kohmei Yamashita, Seiko Yamano

Abstract read
In one paragraph

Article in Clinical and experimental pharmacology & physiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jinyao LiuStudent Medical Academia Investigation Lab, Yamaguchi University Graduate School of Medicine, Ube, Japan.ORCID https://orcid.org/0000-0003-3857-5259
Kohmei YamashitaStudent Medical Academia Investigation Lab, Yamaguchi University Graduate School of Medicine, Ube, Japan.
Seiko YamanoLife Science Division, Yamaguchi University Advanced Technology Institute, Ube, Japan.

Funding

Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS) 23K21526
6 · The paper itself

Abstract

objectiveMetabolic dysfunction-associated steatohepatitis (MASH) is increasingly linked to cardiovascular complications; however, the mechanisms underlying the association between hepatic injury and cardiotoxicity remain unclear. This study aimed to establish a wild-type mouse model of MASH with cardiac involvement and to characterise the temporal relationship between hepatic and cardiac alterations during disease progression.

methodsMale C57BL/6J mice were fed a standard diet or a low-carbohydrate, high-protein, high-cholesterol (LCHP-HC) diet with or without non-excessive ethanol for 12 or 24 weeks. Arrhythmogenic susceptibility was assessed using provocation testing. Hepatic and cardiac alterations were evaluated by histology, immunofluorescence, and quantitative RT-PCR.

resultsThe LCHP-HC diet combined with ethanol induced histological MASH and markedly increased susceptibility to lethal arrhythmias. At 12 weeks, cardiac remodelling characterised by inflammation, mild fibrosis, and connexin-43 dysregulation was evident in the absence of hepatic fibrosis, indicating early cardiotoxic remodelling. At 24 weeks, hepatic fibrosis and hepatic sympathetic activation became evident, whereas local cardiac sympathetic activation remained unchanged, indicating a temporal dissociation in which cardiac remodelling preceded hepatic fibrotic progression.

conclusionEarly cardiotoxic remodelling preceded hepatic fibrosis and was associated with increased arrhythmogenic susceptibility during MASH progression. These findings demonstrate that cardiac remodelling develops early in experimental MASH and reveal a stage-dependent temporal association between hepatic disease progression and cardiac vulnerability.

Indexed as

Arrhythmias, CardiacCardiotoxicityLiver CirrhosisAnimalsConnexin 43Disease SusceptibilityLiverMaleMiceMice, Inbred C57BLConnexin 43cardiotoxicityLCHP‐HC dietlethal arrhythmialiver–heart interactionsMASHnon‐excessive alcohol

Identifiers

PMID42642864
PMCPMC13507369

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.